Ligand validation:7JIR

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7JIR_MES_A_510	16%	64%	0.239	0.805	0.9	0.48	-	-	0	0	100%	1
7KG3_MES_A_203	98%	10%	0.066	0.989	1.58	2.71	1	5	0	0	100%	1
6WCF_MES_A_201	91%	56%	0.098	0.984	0.75	0.95	1	-	0	0	100%	1
6YWM_MES_A_201	85%	62%	0.098	0.964	0.9	0.58	-	-	2	0	100%	1
6W6Y_MES_B_201	79%	64%	0.104	0.949	0.8	0.6	-	-	0	0	100%	0.7
7JIW_MES_A_510	63%	67%	0.157	0.952	0.84	0.45	-	-	0	0	100%	1
2IUY_MES_B_1355	100%	9%	0.026	0.997	1.73	2.73	1	7	0	0	100%	1
3DPJ_MES_A_192	100%	8%	0.022	0.995	2.2	2.41	1	6	3	0	100%	1
9K7M_MES_A_401	100%	67%	0.022	0.998	0.69	0.57	-	-	0	0	100%	1
5TNY_MES_A_501	100%	10%	0.03	0.994	1.72	2.64	1	6	0	0	100%	1
5A0C_MES_B_1002	100%	11%	0.033	0.993	1.84	2.39	3	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.